Filing Details

Accession Number:
0001567619-21-011579
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-02 21:02:06
Reporting Period:
2021-06-01
Accepted Time:
2021-06-02 21:02:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1704292 Zai Lab Ltd ZLAB Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1835836 Chul Ki William Cho C/O Zai Lab Limited
4560 Jinke Road, Bldg 1, 4Th Floor
Pudong, Shanghai F4 201210
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2021-06-01 8,584 $180.12 51,416 No 4 S Direct
Ordinary Shares Disposition 2021-06-02 1,416 $180.69 50,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 19, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.